Commencez
ReutersReuters

FibroGen Announces Positive Type C Meeting With The FDA For Roxadustat In Patients With Anemia Associated With Lower-Risk Myelodysplastic Syndromes

RefinitivMoins d'1 minute de lecture
FGEN

FibroGen Inc FGEN:

  • FIBROGEN ANNOUNCES POSITIVE TYPE C MEETING WITH THE FDA FOR ROXADUSTAT IN PATIENTS WITH ANEMIA ASSOCIATED WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES

Actions américainesReuters
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Connectez-vous ou créez un compte gratuit à vie pour lire ces nouvelles

Plus de nouvelles provenant de Reuters